✦ LIBER ✦

Rotterdam Aphasia Therapy Study (RATS) – 3: “The efficacy of intensive cognitive-linguistic therapy in the acute stage of aphasia”; design of a randomised controlled trial

✍ Scribed by Femke Nouwens, Diederik WJ Dippel, Marjolein de Jong-Hagelstein…

Book ID: 120704202
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 552 KB
Volume: 14
Category: Article
ISSN: 1468-6708
DOI: 10.1186/1745-6215-14-24

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rotterdam Aphasia Therapy Study (RATS) –

Rotterdam Aphasia Therapy Study (RATS) – 3: “The efficacy of intensive cognitive-linguistic therapy in the acute stage of aphasia”; design of a randomised controlled trial

✍ Femke Nouwens, Diederik WJ Dippel, Marjolein de Jong-Hagelstein… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 552 KB

## Background Aphasia is a severely disabling condition occurring in 20 to 25% of stroke patients. Most patients with aphasia due to stroke receive speech and language therapy. Methodologically sound randomised controlled trials investigating the effect of specific interventions for patients with a

What is the research question?: A case s

What is the research question?: A case study in the early stages of design of a randomised controlled trial for a complementary therapy

✍ A. Hart 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Effects of stimulus intensity on the eff

Effects of stimulus intensity on the efficacy and safety of twice-weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial

✍ Titus SP Mohan; Prathap Tharyan; Jacob Alexander; Nirmal S Raveendran 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

The DARE study of relapse prevention in

The DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring

✍ Frances Shawyer; Graham N Meadows; Fiona Judd; Paul R Martin; Zindel Segal; Leon 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 699 KB

Rationale and design of the Anti-Xa Ther

Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

✍ C. Michael Gibson; Jessica L. Mega; Paul Burton; Shinya Goto; Freek Verheugt; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 428 KB